BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation theory motivation to maintain current attitudes and beliefs, but weak enough that the receiver will refute the counterargument (Compton, 2013; McGuire, 1964). Inoculation has been proven successful through trials and research. This article highlights vital aspects of inoculation theory, however, it is not exhaustive–there is a large volume of quality research on the theory not mentioned. Finally, while numerous studies have tested and verified the efficacy of the inoculation process, there continues to be a need for refinement and elaboration. Inoculation theory is used today as part of the suite of tools used by those engaged in shaping or manipulating public